OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in HER2-Targeted Treatment for Advanced/Metastatic Urothelial Carcinoma
Mengnan Qu, Li Zhou, Xieqiao Yan, et al.
Bladder (1970) Vol. 10, Iss. 1, pp. 1-1
Open Access | Times Cited: 10
Mengnan Qu, Li Zhou, Xieqiao Yan, et al.
Bladder (1970) Vol. 10, Iss. 1, pp. 1-1
Open Access | Times Cited: 10
Showing 10 citing articles:
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase 1b/2 dose-escalation and dose-expansion study
Li Zhou, Kun Yang, Shucai Zhang, et al.
Annals of Oncology (2024)
Closed Access | Times Cited: 5
Li Zhou, Kun Yang, Shucai Zhang, et al.
Annals of Oncology (2024)
Closed Access | Times Cited: 5
Non-invasive assessment of HER2 expression in patients with urothelial carcinoma using [68Ga]Ga-HER2 affibody PET/CT imaging: preliminary clinical findings
Sijuan Zou, Zheng Liu, Jianyuan Zhou, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Sijuan Zou, Zheng Liu, Jianyuan Zhou, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Efficacy and safety of disitamab vedotin in combination with immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma
Jianfeng Yao, Jia-Lei Zhong, Qiang Zhou, et al.
World Journal of Urology (2025) Vol. 43, Iss. 1
Closed Access
Jianfeng Yao, Jia-Lei Zhong, Qiang Zhou, et al.
World Journal of Urology (2025) Vol. 43, Iss. 1
Closed Access
Efficacy and safety of DV in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: Results of a phase 2 study
Xieqiao Yan, Juan Li, Huayan Xu, et al.
Med (2025), pp. 100637-100637
Closed Access
Xieqiao Yan, Juan Li, Huayan Xu, et al.
Med (2025), pp. 100637-100637
Closed Access
A phenotypic screen identifies xanthohumol and other flavonoids as killers of bladder cancer
Michael J. Bolt, Jessica Oceguera, Alejandra Rivera Tostado, et al.
Pharmacological Research - Natural Products (2025), pp. 100236-100236
Closed Access
Michael J. Bolt, Jessica Oceguera, Alejandra Rivera Tostado, et al.
Pharmacological Research - Natural Products (2025), pp. 100236-100236
Closed Access
Recombinant retroviral vectors that express EGF, TGF alpha, NRG2 beta, and the NRG2 beta Q43L mutant v2
Ella Wilson
(2024)
Open Access | Times Cited: 1
Ella Wilson
(2024)
Open Access | Times Cited: 1
New Advances in Metastatic Urothelial Cancer: A Narrative Review on Recent Developments and Future Perspectives
Elena Tonni, Marco Oltrecolli, Marta Pirola, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9696-9696
Open Access | Times Cited: 1
Elena Tonni, Marco Oltrecolli, Marta Pirola, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9696-9696
Open Access | Times Cited: 1
Prognostic and Predictive Roles of HER2 Status in Non-Breast and Non-Gastroesophageal Carcinomas
Erica Quaquarini, Federica Grillo, Lorenzo Gervaso, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3145-3145
Open Access | Times Cited: 1
Erica Quaquarini, Federica Grillo, Lorenzo Gervaso, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3145-3145
Open Access | Times Cited: 1
Case Report: Successful Treatment of Advanced Urothelial Carcinoma with Trophoblastic Differentiation Using Tislelizumab and Disitamab vedotin
Yaqian Han, Yujuan Zhou, Zheng Wu, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38518-e38518
Open Access
Yaqian Han, Yujuan Zhou, Zheng Wu, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38518-e38518
Open Access
Use of 3′ Rapid Amplification of cDNA Ends (3′ RACE)-Based Targeted RNA Sequencing for Profiling of Druggable Genetic Alterations in Urothelial Carcinomas
Natalia V. Mitiushkina, Vladislav I. Tiurin, Aleksandra A. Anuskina, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12126-12126
Open Access
Natalia V. Mitiushkina, Vladislav I. Tiurin, Aleksandra A. Anuskina, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12126-12126
Open Access
